SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib.

SK119 是一种新型紫草素衍生物，可导致黑色素瘤细胞系凋亡，并与维莫非尼和考比替尼表现出协同作用